Stella is a doctoral researcher at Charité Berlin, where she investigates optimal design of vaccination centers drawing on machine learning techniques and policymaker insights.

Stella has always been passionate about healthcare innovation in underserved areas. Accordingly, she has built an interdisciplinary profile combining private and public sector experience at local, national and international level in healthcare. She studied health economics, politics, and history at Sciences Po Paris, London School of Economics, and London School of Hygiene and Tropical Medicine.

Following her studies, she worked as a project manager and consultant with a focus on market access and business strategy at the OECD, the Red Cross, the German Federal Ministry of Health and McKinsey & Co. 

At McKinsey, Stella advised clients across pharma, medtech and global public health. When the COVID-19 pandemic broke out, she joined the German Ministry of Health’s COVID response unit, coordinating the development of national testing and vaccination strategies.

Stella augmented her strategic skillset with more hands-on experience in product design and innovation as a Biodesign Innovation Fellow at Stanford University in emergency medicine and as mentor for social innovation and healthcare start-ups, with a focus on women's health projects.

Stella is currently based in Europe. In her free time, she enjoys hiking, surfing, board games, and DIY projects.

‍

MOST INFLUENTIAL CONTENT READ LAST YEAR

Re-read Daniel Kehlmann’s “Measuring the World”. The novel juxtaposes two ways of exploring planet earth and how it works: on one side geographer Humboldt’s empirical exploration hiking mountains, measuring trees, collecting specimen. On the other side, mathematician Gauss’ theoretical exploration through equations.

‍

WHAT EXCITES YOU ABOUT ARTIS

The bold multifaceted vision of future healthcare, investment with a platform lens, and a fantastic team!

‍

HEALTHCARE ADVANCEMENT YOU HOPE TO SEE IN YOUR LIFETIME

Healthcare services and financing mechanisms that allow for equitable access to novel therapies independent of individual wealth, location and origin.